Press Release
Phnom Penh – Jakarta – Beijing, December 4, 2024 – Mitosis Bioscience Co., Ltd. announced that it held a virtual meeting with regional representatives of Sinovac Biotech Ltd. (Nasdaq: SVA), one of the world’s leading vaccine manufacturers.
The meeting, joined by Mr. Jonas and Ms. Xinge, Business Development Managers from Sinovac, and Dr. Tam and Dr Elin, Co-Founders of Mitosis Bioscience, focused on opening pathways for vaccine import into Cambodia. Both parties expressed strong interest in establishing long-term cooperation to improve vaccine accessibility and strengthen Cambodia’s immunization efforts.
This milestone discussion paves the way for a fruitful partnership between Sinovac and Mitosis, reflecting a shared commitment to protecting public health and advancing preventive healthcare in Cambodia.
“Life above all.Quality Vaccine. Evidence-Based.”